Case Study

Ulcerative Colitis

An Open-Label Proof-of-Concept Study
A new compound for Ulcerative Colitis
An open-label, proof of concept study to assess the safety, and explore the efficacy of a new compound in patients with active mild-to-moderate Ulcerative Colitis (UC).
After 5 months of active recruiting, the seven trial sites had not enrolled enough patients. A fundamental challenge of recruiting patients for any UC study is the low prevalence of UC indication and the random nature of flareups. It takes an experienced recruiting provider to know how to target and engage prospective UC patients. For this particular study, a further complication was other available competitive studies which confused patients. Several vaccine requirements and complicated Inclusion/Exclusion criteria excluded large percentages of referred patients.
The nRollmed Method
process infographic
process for mobile
Book a discovery call
Book a discovery call
Svces pg Awareness campaigns icon
of all patients recruited
Svces pg Prescreening icon
months to reach recruitment goals

nRollmed provided 50% of patients in 3 months

To discuss your study needs and how we can help recruit patients faster